Healthy :: World-first living intestine study points to new generation of food and medicines
Massey scientists have discovered a weak link in human digestion that could revolutionise healthy eating and medical treatment for the chronically-ill.
Massey scientists have discovered a weak link in human digestion that could revolutionise healthy eating and medical treatment for the chronically-ill.
Despite modest overall improvements in breast cancer survival rates for women with advanced disease over the last two decades, the rates for black women have not improved and the difference in life expectancy between white and black women continues to widen, according to researchers at the University of Texas M. D. Anderson Cancer Center.
Researchers have discovered the first inherited gene mutation that increases a person’s risk for chronic lymphocytic leukemia (CLL), one of the most common forms of the disease.
An apple a day keeps the doctor away? Or, what appears to be more accurate: An apple peel a day might help keep cancer at bay, according to a new Cornell study.
While orange cauliflower may seem unappealing to some, it has distinct nutritional advantages. Now, Cornell researchers have identified the genetic mutation behind the unusual hue.
A researcher in the Oregon Health & Science University Cancer Institute and Portland Veterans Affairs Medical Center has found a way to identify which men need a second prostate biopsy because they may be harboring life-threatening prostate cancer even though they were given a clean bill of health after their first biopsy.
An established second-line drug for chronic myelogenous leukemia has high response rates when given to newly diagnosed patients as their first therapy for the disease, according to early results from a phase II clinical trial at the University of Texas M. D. Anderson Cancer Center.
The simple notion of copying the body?s own natural “waste disposal” chemistry to mop up potentially toxic nitrogen has saved an estimated 80 percent of patients with urea cycle disorders — most of them children ? according to a report in this week?s New England Journal of Medicine summarizing a quarter century of experience with the treatment.
Higher levels of a protein called S-100 in patients with melanoma may correlate with a higher risk of having the disease return, say researchers at the University of Pittsburgh Cancer Institute (UPCI), who presented their findings today at the annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago.
In the first scientific study of its kind, shark cartilage extract, AE-941 or Neovastat, has shown no benefit as a therapeutic agent when combined with chemotherapy and radiation for patients with advanced non-small cell lung cancer, according to researchers at the University of Texas M. D. Anderson Cancer Center.